Vor Bio to Participate in Upcoming Investor Conferences
06 5월 2024 - 9:00PM
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering
company, today announced that it will participate in the following
upcoming investor conferences:
The Citizens JMP Life Sciences Conference
Fireside Chat: Tuesday, May 14, 2024 at 11:00 am ET Location: New
York, NY
A live webcast and archived replay of the fireside chat will be
available on the investors section of www.vorbio.com.
H.C. Wainwright 2nd Annual BioConnect Investor
ConferenceFireside Chat: Monday, May 20, 2024 at 10:30 am
ET Location: New York, NY
About Vor BioVor Bio is a clinical-stage cell
and genome engineering company that aims to change the standard of
care for patients with blood cancers by engineering hematopoietic
stem cells to enable targeted therapies post-transplant. For more
information, visit: www.vorbio.com.
Contact:
Media & InvestorsSarah Spencer +1
857-242-6076sspencer@vorbio.com
Vor Biopharma (NASDAQ:VOR)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Vor Biopharma (NASDAQ:VOR)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
